68Gallium-prostate-specific membrane antigen ligand positron-emission tomography or computed tomography in biochemical failure after radical prostatectomy: A case report

South African Journal of Oncology

ARTICLE

Irene A. Chidothe¹  David B. Anderson¹ 

[1] Department of Radiation Oncology, Faculty of Healthy Sciences, University of Cape Town, Groote Schuur Hospital

关键词: prostate cancer;    biochemical failure;    68Ga-PSMA PET/CT;   

DOI  :  10.4102/sajo.v1i0.16

学科分类：工业工程学

来源: AOSIS

【 摘 要 】

Biochemical failure after radical treatment for prostate cancer occurs in up to 30% – 50% of cases. Localisation of clinical disease is challenging because clinical symptoms often manifest long after the initial rise in prostate-specific antigen. The detection rates of imaging modalities such as contrasted computed tomography (CT), bone scan, magnetic resonance imaging and choline positron-emission tomography (PET) or CT, are limited. Prostate-specific membrane antigen (PSMA) ligand PET or CT is a novel imaging modality under investigation for various diagnostic and therapeutic indications in the management of prostate cancer. We present a case report illustrating how 68 Gallium-PSMA ligand PET or CT was used to guide management in a patient presenting with biochemical failure after radical prostatectomy.

【 授权许可】

CC BY